Tip:
Highlight text to annotate it
X
RESEARCH BASED INFOGRAPHICS SHOW WHAT PSYCHIATRIC PHARMACEUTICALS ARE REALLY DOING TO US
BY Alex Pietrowski
The drugging of the American public is one of those strange, well-known, but under-discussed
issues that�s never quite fully represented in the conversation about where our culture
is and where it�s heading.
As of 2016, one in six American adults were taking psychiatric medications, a staggering
number that is accompanied by the fact that the mental health industry in America is worth
well over $200 billion a year.
We�ve been led to believe that our doctors are the end-all-be-all authority on what�s
good for our health and that their advice is backed up by rigorous and undeniable scientific
proof.
What we�re not told, however, is that scientific research today is highly suspect and often
outright corrupted by the pharmaceutical industry.
Furthermore, we really don�t yet understand the full-range of consequences involved in
taking prescriptions psychiatric medications instead of pursuing other, natural possibilities.
Medical researcher Craig Wagner has compiled eight years of study of psychiatric medications
and their effects, and he has distilled his findings into three easy to grasp infographics
that will shatter your perceptions about the efficacy and safety of these medications.
We really don�t have a truthful understanding of this issue, but these graphics will help
put it into perspective.
This first graphic looks at antidepressants.
Wagner writes:
�The FDA and meta-analyses tell us that the advantage of antidepressants over placebo
for treating depression is razor thin; so small, in fact, that most people can�t tell
the difference.
To gain this small advantage people must accept antidepressants� side effects, risks, and
limitations which can be significant.
Even more startling, at milder symptom levels � representing about 85% of people taking
these drugs for depression � antidepressants have no advantage over placebo.�
The following graphic looks at antipsychotics.
Again, the graphic is further explained by Craig Wagner:
�For many people, antipsychotics reduce psychosis.
But less than a quarter of those with chronic psychosis see even a 50% reduction in symptoms
when using them.
And this partial symptom relief often comes with life-altering side effects.
Additionally, evidence suggests that antipsychotics may do more harm than good in the long term.�
The third graphic examines benzodiazepines.
Wagner comments:
�Benzodiazepines can reduce anxiety, often quickly.
But prescribing guidelines say their use should be restricted to very short durations.
There is good reason: significant cognitive decline and potentially life-threatening withdrawal
make them a questionable solution beyond episodic anxiety.�
The research and supporting graphics paint a more realistic picture of what psychiatric
medications are actually doing to people.
As more data is collected with each passing year, we�re learning that the pharmaceutical
industry is not necessarily seeking to improve public health.